The ability to self-renew is one of the most important properties of embryonic stem (ES) cells. Pluripotin (SC1), a small molecule with high activity and low toxicity, promotes self-renewal in mouse ES cells. SC1 can noticeably change the morphology of retinoic acid (RA)-induced F9 embryonic carcinoma cells (F9 cells). However, in the long term, RA and SC1 together cause cell apoptosis. When being added after 18-24 h of RA-induced F9 cell differentiation, SC1 transitorily activated Nanog and Oct4. Both Nanog and Oct4 were downregulated when SC1 and RA were added simultaneously. On the other hand, Klf4 was continually activated when SC1 was added between 6 and 24 h. Phosphorylated Erk1/2 protein levels were reduced from 6 to 24 h, whereas unphosphorylated Erk1 protein levels remained unchanged. A higher concentration of SC1 promoted cell self-renewal by strengthening the inhibition of Erk1/2 protein phosphorylation in F9 cells. Furthermore, SC1 and RA affect global DNA methylation by influencing the expressions of methylation-associated proteins, including Dnmt3b, Dnmt3l, Tet1, Tet2, and Tet3. In conclusion, SC1 inhibits the differentiation of RA-induced F9 cells mainly by reducing the levels of phosphorylated Erk1/2 and enhancing the expression of Klf4, although it also reduces DNA methylation, which may have an additional effect on ES cell differentiation.
Introduction
The ability to self-renew is one of the most important properties of embryonic stem (ES) cells, and their initial undifferentiated state is necessary for the success of regenerative medicine, alternative therapies, and disease research [1, 2] . The molecular mechanisms and signaling pathways that maintain pluripotency and promote selfrenewal in murine ES cells are very complex, but it is generally accepted that four signaling pathways are involved: Jak/Stat, BMP/ Smad, Wnt, and Mek/Erk. The Jak/Stat signaling pathway promotes self-renewal by inhibiting mesoderm and endoderm differentiation via the phosphorylation of Stat3 [2, 3] . The BMP/Smad signaling pathway inhibits neuroectoderm differentiation depending on the induction of Id gene expression via BMP4 [1] . The Wnt signaling pathway maintains pluripotency in mouse ES cells via the inhibition of glycogen synthase kinase 3 (Gsk3) [4] . The Mek/Erk signaling pathway induces ES cell differentiation via the direct phosphorylation of Klf4 at Ser123 by Erk1 or Erk2, which suppresses Klf4 activity [5] .
Some small-molecule modulators may affect these signaling pathways, which directly activate pluripotency genes, inhibit differentiation genes to keep ES cells in a pluripotent state, and maintain their capacity for self-renewal. For example, mouse ES cell pluripotency can be maintained in CHIR99021 and PD0325901 medium supplemented with serum-free N2B27 [6] . CHIR99021 activates the canonical Wnt/β-catenin signaling pathway by inhibiting Gsk3, which can phosphorylate β-catenin, to ensure the stabilization and nuclear translocation of β-catenin [7, 8] . Other small molecules, such as BIO [9] and TWS119 [10] , can inhibit Gsk3. PD0325901 inhibits mitogen-activated protein kinase (Mek) in the Mek/Erk signaling pathway [8, 11] . Previous studies have shown that small-molecule compounds can greatly improve the efficiency of reprogramming [12] . Researchers have demonstrated that chemically induced pluripotent stem cells can be generated from mouse somatic cells by using a combination of seven small-molecule compounds; and the resulting cells resemble ES cells in all aspects [13] . Nowadays, an increasing number of small molecules are being used as tools to modulate signaling pathways in stem cell research.
Pluripotin (SC1), a small molecule with high activity and low toxicity, can maintain the self-renewal of mouse ES cells by inhibiting RasGAP and Erk1 [14] . Mouse ES cells can maintain their morphology and ability to self-renew in the absence of leukemia inhibitory factor in SC1 medium [15] . SC1 can repress the expressions of Tet1 and Tet2 to promote the expression of Oct4 in J1 mouse ES cells, thus suggesting that SC1 may affect the DNA methylation level of mouse ES cells [16] . In F9 cells, the addition of SC1 can maintain and induce compact colony morphology partly by modulating E-cadherin in the culture medium, but it cannot alter cell proliferation or cell viability [17] . SC1 also significantly upregulates miR124-3p expression and further inhibits the Mek/Erk pathway by targeting Grb2, Sos2, and Egr1 [18] . Although these studies have indicated that SC1 can effectively maintain the capacity for self-renewal, the specific mechanisms and DNA methylation patterns of SC1 that inhibit the differentiation of mouse stem cells are still unknown.
Materials and Methods

F9 cell culture
Mouse F9 cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured on tissue culture plates coated with 0.1% gelatin. The culture medium was KnockOut™ Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Cells were maintained at 37°C in a moist atmosphere of 95% air and 5% CO 2 .
Reagents and antibodies
Dimethyl sulfoxide (DMSO), retinoic acid (RA), and SC1 were purchased from Sigma-Aldrich (St Louis, USA). Primary antibodies, including mouse anti-Oct4, rabbit anti-Klf4, mouse anti-Erk1, and mouse anti-p-Erk1/2 (12D4) (phospho-Thr-202/Tyr-204), were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, USA). Rabbit anti-Nanog polyclonal antibody was obtained from Cell Signaling Technology (Danvers, USA). Rabbit anti-5-methylcytosine antibody and rabbit anti-5-hydroxymethyl cytosine antibody were purchased from Active Motif (Carlsbad, USA). Mouse anti-Dnmt3a, mouse anti-Dnmt3l, mouse anti-Tet3, and mouse anti-β-tubulin monoclonal antibodies were procured from TransGen Biotech (Beijing, China). The Alexa Fluor 555-labeled donkey anti-mouse IgG(H+L), DAPI, BCIP/NBT Alkaline Phosphatase Color Development kit and HRP-labeled goat anti-rabbit IgG(H+L), HRP-labeled goat anti-mouse IgG(H+L) were purchased from the Beyotime Institute of Biotechnology (Haimem, China). The Cell Counting kit (CCK) was purchased from TransGen Biotech.
SC1 and RA treatment
SC1 and RA were dissolved in DMSO to a concentration of 10 and 1 mM, respectively, and stored at −20°C. Cell medium with an equal volume of DMSO was used as a control. The cells were incubated with different working concentrations of SC1 6 or 24 h. The working concentration of RA was 1 μM. SC1 and RA were directly added to the prewarmed cell culture medium.
Reverse-transcription PCR and quantitative real-time PCR
Gene expression levels in differently treated cells were validated by quantitative real-time polymerase chain reaction (qPCR) analysis using the ABI StepOne Plus PCR System (Applied Biosystems, Foster City, USA). Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, USA), and extracted RNA (1 μg) was reverse transcribed into cDNA by using the SYBR PrimeScript RT Reagent kit (Perfect Real Time; TaKaRa, Dalian, China) according to the manufacturer's instructions. The forward and reverse primers for qPCR are listed in Table 1 . The reaction conditions were 95°C for 30 s, 40 cycles at 95°C for 5 s, and 60°C for 30 s. The relative expression levels of genes were calculated using the 2 −ΔΔCT method by using the glyceraldehyde 3-phosphate dehydrogenase housekeeping gene (GAPDH) for normalization.
Western blot analysis
Equal amounts of proteins were separated on 10% polyacrylamide gels and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, USA) at 250 mA for 2 h. The PVDF membranes were blocked with 10% non-fat milk at room temperature for 3 h and then incubated at 4°C overnight with primary antibody. Membranes were incubated with secondary antibody at room temperature for 2 h after three times (10 min each time) of wash 
Forward TGCGATTGTGTCGAACAAATAGT Reverse TCCATACCGATCCTCCATGA with TBST (containing 0.1% Tween-20). Antibody dilution was performed according to the application preference. Immunoblots were revealed by autograph via the Gel Doc™ XR + Gel documentation system (Bio-Rad, Hercules, USA).
Determination of cell viability
Cell suspension was inoculated into a 96-well plate (100 μl/well), which was then preincubated in a humidified incubator at 37°C with 5% CO 2 . Approximately 10 μl of CCK-8 solution was added to each well; care was taken not to introduce bubbles into the wells because bubbles could interfere with the OD reading. The plate was incubated for 1-4 h, and the absorbance at 450 nm was measured using a microplate reader.
Immunofluorescence staining and alkaline phosphatase staining F9 cells were cultured to be stained in 24-well plates. The cells were washed three times with PBS and were then fixed with 4% paraformaldehyde for 20 min. After being washed three times with PBST (containing 0.25% Triton X-100), cells were blocked for 1 h with Immunol staining blocking buffer (Beyotime) and then incubated with diluted primary antibodies at 4°C overnight. Cells were washed three times with PBST and then incubated with diluted DyLight 555-conjugated secondary antibodies (Beyotime) at room temperature for 2 h in the dark. DNA was stained with DAPI for 15 min at room temperature. Normal and stained cells were observed and photographed using an inverted fluorescence microscope (Nikon, Tokyo, Japan) The alkaline phosphatase (AP) activity of cells was measured using the BCIP/NBT Alkaline Phosphatase Color Development kit (Beyotime). Cells fixed in 4% paraformaldehyde were incubated in a BCIP/NBT working solution for 30 min in the dark. Staining was terminated with distilled water. Normal and stained cells were observed and photographed using an inverted fluorescence microscope (Nikon).
Statistical analysis
Data are expressed as the mean ± standard deviation (SD). Differences between groups were analyzed by the two-tailed paired Student's t-test, and P values <0.05 were considered significant.
Results
Identification of morphological changes and genes induced in F9 cells by RA and/or SC1 at different time points RA, a metabolite of vitamin A, can promote stem cell differentiation and neural lineage specification to produce neurons [19] . To investigate the effects of SC1 and/or RA on F9 cells, cells were cultured with 1 μM SC1 and either 1 μM RA or an equal volume of DMSO for 24, 48, and 72 h. It was found that some F9 cells changed morphologically, becoming less round and more spindle-shaped after 48 h of RA treatment. Most cell morphologies changed after 72 h. After 24 h of treatment with 1 μM SC1, F9 cell boundaries became smooth and many cells clustered together to form a colony. When RA-induced F9 cells were treated with SC1 for 24 h, cell morphologies were generally similar to those of cells cultured in SC1-only medium. After 48 h, many cells were separated, and few cells remained adhered to one another at 72 h (Fig. 1A) . Then cell viability was assessed by CCK assay after treatment with 1 μM RA, SC1, RA + SC1, or DMSO, for 0, 24, 48, and 72 h. Treatment with DMSO, SC1 alone had no significant effect on cell viability at 0, 24, 48 and 72 h. But RA, or RA + SC1 strongly inhibited cell viability (Fig. 1B) . Nanog, Oct4, Sox2, and Klf4 are core stem cell markers [20] [21] [22] . The qPCR analysis of those genes in the RA-treated F9 cells showed that the expressions of Nanog, Oct4, and Sox2 were continuously decreased with time. The expression of Klf4 in RAtreated cells was decreased at 24 h but began to increase after 48 h (Fig. 1C) . Western blot analysis of Nanog at different time points showed that Nanog was temporarily activated after treatment for 4-10 h with 1 μM SC1 (Fig. 2D) , and this result is consistent with the results of qPCR analysis (Fig. 1E) .
These results indicated that cell differentiation was induced in RA-treated F9 cells. The addition of SC1 may inhibit RA-induced differentiation, but this will eventually cause cell death.
The expressions of pluripotency and differentiation factors changed during the inhibition of RA-induced differentiation by SC1
To elucidate the mechanism whereby SC1 inhibits RA-induced differentiation in F9 cells, the expressions of related genes were explored. Given that SC1 transiently activates the pluripotency factor Nanog, SC1 treatment was performed at two time points, namely, 6 and 24 h. As shown in Fig. 2A , the transcription levels of Nanog, Oct4, and Klf4 were significantly increased at 6 h in SC1-treated F9 cells but returned to the initial level at 24 h. After 18 h, at which point RA induced the differentiation of F9 cells, the expression levels of Nanog and Oct4 were upregulated, as shown by qPCR. However, the expressions of these genes were still downregulated when cells were treated with SC1 and RA at the same time for 24 h. In SC1-treated F9 cells, the key pluripotency gene Klf4 was continually upregulated from 6 to 24 h. The expression of Erk1 did not significantly change at 6 and 24 h in SC1-treated F9 cells accompanied by RA-induced differentiation for 24 h. The protein levels of the pluripotency factors Nanog, Oct4, and Klf4 after 6 and 24 h of SC1 treatment were consistent with the results of qPCR. SC1 did not change Erk1 protein levels, but it inhibited the phosphorylation of Erk1/2 at 6 and 24 h in RA-induced F9 cells, and the results after 24 h are more significant than those at 6 h (Fig. 2B) . Immunofluorescence staining was conducted to examine the changes of Nanog. The results are consistent with those of qPCR and western blot experiments. RA treatment results after 48 h were similar to those after 24 h in F9 cells given SC1 inhibition differentiation at 6 and 24 h.
The above results indicate that SC1 can temporarily promote the expressions of pluripotency factors Nanog and Oct4, thus continually promoting Klf4 and inhibiting the phosphorylation of the differentiation-related Erk1/2 protein in RA-induced F9 cells.
The effects of different concentrations of SC1 on RA-induced F9 cells SC1 is highly effective and relatively non-toxic and does not affect F9 embryonic carcinoma (EC) cell proliferation and viability [14, 17] . Therefore, experiments were conducted to examine if a significant increase of SC1 concentration can inhibit RA-induced differentiation more effectively. AP activity in 3 μM SC1-treated F9 cells was similar to that of cells treated with 1 μM SC1. However, it was found that the activation of AP cells treated with SC1 for 24 h was higher than that at 6 h, regardless of the presence of RA (Fig. 3A) . Thereafter, the effect of 1 μM or 3 μM SC1 treatment at 6 and 24 h on Nanog, Oct4, Klf4, Erk1, and p-Erk1/2 levels were analyzed by western blot analysis. The results showed that when the cells were treated with 3 μM SC1, the levels of Nanog, Oct4, and Klf4 were all higher than those after 1 μM SC1 treatment. There was no obvious change at Nanog and Oct4 protein levels with two concentrations of SC1 treatment for 24 h compared with the control cells. After 24 h of 1 μM or 3 μM SC1 treatment, Klf4 protein levels were similar to those at 6 h, but all were significantly higher than those of the control. Erk1 protein levels were not significantly changed at different time points or at different concentrations of SC1. However, p-Erk1/2 protein levels were significantly decreased with increasing time and concentration of SC1 (Fig. 3B) . When F9 cells were treated with RA and 1 or 3 μM SC1 for 24 h, the Nanog, Oct4, and Klf4 protein levels did not change. However, different concentrations of SC1 significantly reduced the phosphorylation of Erk1/2, which was caused by RA treatment, and a higher concentration of SC1 causes a more obvious effect (Fig. 3C) .
These results demonstrate that although a higher concentration of SC1 cannot change the expressions of pluripotency genes in RAinduced F9 cells over 24 h, it can maintain the self-renewal of cells by strengthening the inhibition of Erk1/2 protein phosphorylation.
SC1 and/or RA induce(s) global DNA methylation level in F9 cells
DNA methylation, which is catalyzed by DNA methyltransferases, represses gene transcription and silences genes. Hence, DNA methylation is essential for maintaining the undifferentiated state of stem cells. To investigate alterations in global DNA methylation in F9 cells when SC1 and/or RA are/is added, immunofluorescence staining was performed to examine the effects on global DNA 5-methylcytosine (5-mC) and 5-hydroxymethyl cytosine (5-hmC) levels. It was found that DNA methylation levels were repressed when SC1 or RA was added at 24 h. This alteration was not obvious when SC1 was added at 6 h. However, in RA-treated F9 cells, the levels of DNA methylation were decreased after SC1 was added at 6 and 24 h (Fig. 4A) . Further experiments revealed that the global DNA 5-hmC level did not match that of 5-mC (Fig. 4B) . Quantitative PCR results indicated that SC1 and/or RA can repress Tet1 and Tet2 expressions, while promoting Tet3 expression in F9 cells. Given the same treatment, although the expression of Dnmt3a did not significantly change, the expressions of Dnmt3b and Dnmt3l were downregulated (Fig. 4C) , thus resulting in similar changes at protein levels of Dnmt3a, Dnmt3l, and Tet3 (Fig. 4D) . These results suggested that SC1 and/or RA modulated F9 EC cell epigenetic modification by altering the expressions of epigeneticassociated genes.
Discussion
SC1 can effectively maintain pluripotency and the capacity for selfrenewal in mouse ES cells. This is mainly due to the inhibition of the Erk signaling pathways via the inhibition of Erk1. However, RA can cause EC cells to differentiate into neurons and glial cells [23] , and this effect depends on the activation of the Erk signaling pathways [24] . Our results confirmed that the phosphorylation of Erk1/2 induced by RA could be effectively inhibited by SC1 in F9 cells, thereby inhibiting RA-induced cell differentiation. However, the competitive action between SC1 and RA can lead to cell apoptosis in the long term (Fig. 1A,B) .
In this study, we found that the core pluripotency factors Nanog and Oct4 were transiently increased in SC1-treated F9 cells, and this phenomenon was related to the inhibition of SC1-induced p53 phosphorylation [25] . Previous studies have shown that SC1 can transiently activate Nanog expression after 6 h in mouse ES cells by inhibiting p53 phosphorylation at Ser315 [14] .
It is well known that Klf4 can promote the self-renewal of mouse ES cells [22, 26, 27] . Our results revealed that Klf4 expression continued to be upregulated with increasing time and SC1 concentration in F9 cells. This may be attributed to the enhancement of Klf4 expression by SC1 through inhibiting Erk1/2, because Erk1/2 can bind to the Klf4 activation domain to promote the phosphorylation of Klf4 and then repress its expression [5] . Therefore, SC1 can inhibit mouse EC cell differentiation by promoting Klf4 expression.
DNA methylation is an essential epigenetic modification for mammalian embryonic development [28] . During mouse development, Dnmt3a and Dnmt3b are involved in de novo methylation [29] . Dnmt3l can interact with and activate Dnmt3a and Dnmt3b, but it is catalytically inactive and highly expressed in mouse ES cells [30] . Furthermore, Tet family genes are also associated with DNA methylation. The main function of Tet proteins is the conversion of 5-mC to 5-hmC, which is important in the dynamic changes of DNA methylation in the process of stem cell differentiation [31, 32] . Interestingly, in our RA and SC1 treatment experiments in F9 cells, the effects on Tet proteins varied greatly, and the related gene expressions were consistent with global DNA methylation and hydroxymethylation levels. It is speculated that global DNA methylation is a complex, dynamic, and balanced process. The direction of stem cell development cannot be estimated only by the methylation status of any given genes. In any case, DNA methylation in stem cells provides a more stable and long-term silencing mechanism for the pluripotent and imprinted genes [33] . 
